Is CDT or GCTK more profitable?

CDT runs the higher net margin — CDT at 6.30% versus GCTK at 0.00%.

CDT Equity Inc. (CDT) vs GlucoTrack, Inc. (GCTK)

A side-by-side comparison of CDT Equity Inc. and GlucoTrack, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CDT

CDT Equity Inc.

$707297

$0.92HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

GCTK

GlucoTrack, Inc.

$885939

$1.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — CDT vs GCTK

growth of $100 · dividends reinvested · last 3y

CDT -100.0% (-99.8%/yr)GCTK -100.0% (-95.5%/yr)GCTK compounded faster over this window

Log scale — wide-divergence pair

CDT GCTK

CDT vs GCTK: by the numbers

•GCTK is the larger company ($885939 vs $707297 market cap).
•CDT is profitable (6.30% net margin) while GCTK runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	CDT	GCTK
P/S ratio	0.00	N/A
P/B ratio	0.00	N/A
EV / EBITDA	4.13	N/A

Profitability

Metric	CDT	GCTK
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	6.30%	0.00%
ROE	6.58%	N/A
ROIC	4.47%	N/A

Growth (annualized)

Metric	CDT	GCTK
Total return CAGR (5Y)	N/A	-92.60%

Frequently asked

Is CDT or GCTK more profitable?: CDT runs the higher net margin — CDT at 6.30% versus GCTK at 0.00%.

Go deeper

Full CDT analysis Full GCTK analysis Interactive comparison tool

Dig into the metrics

CDT Equity ROE GlucoTrack ROE CDT Equity operating margin GlucoTrack operating margin CDT Equity revenue growth GlucoTrack revenue growth CDT Equity free cash flow GlucoTrack free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.